• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参活性成分的分离及其在癌症转移辅助治疗中的作用。

Separation of ginseng active ingredients and their roles in cancer metastasis supplementary therapy.

机构信息

Cancer Metastasis Alert and Prevention Center, College of Chemistry and Chemical Engineering, Fuzhou University, Fuzhou 350002, China.

出版信息

Curr Drug Metab. 2013 Jun;14(5):616-23. doi: 10.2174/13892002113149990003.

DOI:10.2174/13892002113149990003
PMID:23701161
Abstract

In Traditional Chinese Medicine (TCM), ginseng roots are taken orally as a pharmacological adaptogen and nourishing stimulants for thousands of years. Along with the rapid advancement of modern life technologies, ginseng's effects as a non-toxic non-organ-specific cancer preventive agent have recently been elucidated both at molecular levels and on clinical aspects. Here we presented some techniques used for separating ginseng active ingredients, evidence of effects of ginseng and its ingredients on cancer and cancer metastasis obtained from in vitro and in vivo experiments and thousands of volunteers participated in various clinical trials. As a biological response modifier and an adaptogen to synergistically enhance efficacy of conventional therapy as a supplement, adequate ginseng consumption reduces the risk of development of all types of cancer and the recurrence of some types of cancer, improves host intrinsic response to cancer and quality of patients' life. We also briefly stated recent case reports on potential interaction between warfarin and ginseng products.

摘要

在中医(TCM)中,人参根被口服作为一种药理学的适应原和滋补兴奋剂已有数千年的历史。随着现代生活技术的快速发展,人参作为一种无毒的非器官特异性癌症预防剂的作用最近在分子水平和临床方面得到了阐明。在这里,我们介绍了一些用于分离人参活性成分的技术,以及人参及其成分对癌症和癌症转移的影响的证据,这些证据来自体外和体内实验以及数千名志愿者参加的各种临床试验。作为一种生物反应调节剂和适应原,可以协同增强常规治疗的疗效作为补充,适量食用人参可以降低各种癌症的发展风险和某些类型癌症的复发风险,提高宿主对癌症的固有反应和患者的生活质量。我们还简要说明了最近关于华法林和人参产品之间潜在相互作用的案例报告。

相似文献

1
Separation of ginseng active ingredients and their roles in cancer metastasis supplementary therapy.人参活性成分的分离及其在癌症转移辅助治疗中的作用。
Curr Drug Metab. 2013 Jun;14(5):616-23. doi: 10.2174/13892002113149990003.
2
A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials.对人参在传统中医中的古代应用与现代药理实验及临床试验的比较。
Phytother Res. 2008 Jul;22(7):851-8. doi: 10.1002/ptr.2384.
3
Panax ginseng: a role in cancer therapy?人参:在癌症治疗中发挥作用?
Integr Cancer Ther. 2003 Mar;2(1):13-33. doi: 10.1177/1534735403251167.
4
Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.当前千年草药-人参的评估 (II):从传统中药中收集的化学实体、现代药理学和临床应用。
Curr Med Chem. 2009;16(22):2924-42. doi: 10.2174/092986709788803204.
5
Use of ginseng in medicine with emphasis on neurodegenerative disorders.人参在医学中的应用,重点关注神经退行性疾病。
J Pharmacol Sci. 2006 Mar;100(3):175-86. doi: 10.1254/jphs.crj05010x. Epub 2006 Mar 4.
6
Radioprotective potential of ginseng.人参的辐射防护潜力。
Mutagenesis. 2005 Jul;20(4):237-43. doi: 10.1093/mutage/gei041. Epub 2005 Jun 14.
7
The antimicrobial properties of ginseng and ginseng extracts.人参及人参提取物的抗菌特性。
Expert Rev Anti Infect Ther. 2016;14(1):81-94. doi: 10.1586/14787210.2016.1118345. Epub 2015 Dec 2.
8
The ginseng's fireness is associated with the lowering activity of liver Na(+)-K(+)-ATPase.人参的温热性与肝脏钠钾ATP酶活性降低有关。
J Ethnopharmacol. 2016 Aug 22;190:241-50. doi: 10.1016/j.jep.2016.06.024. Epub 2016 Jun 8.
9
The effects of Panax ginseng on quality of life.人参对生活质量的影响。
J Clin Pharm Ther. 2003 Feb;28(1):5-15. doi: 10.1046/j.1365-2710.2003.00467.x.
10
[Ginseng prescription rules and molecular mechanism in treating coronary heart disease based on data mining and integrative pharmacology].基于数据挖掘和整合药理学的人参治疗冠心病的用药规律及分子机制研究
Zhongguo Zhong Yao Za Zhi. 2018 Apr;43(7):1303-1309. doi: 10.19540/j.cnki.cjcmm.20180115.006.

引用本文的文献

1
Fuyuan decoction prevents nasopharyngeal carcinoma metastasis by inhibiting circulating tumor cells/ endothelial cells interplay and enhancing anti-cancer immune response.复元汤通过抑制循环肿瘤细胞/内皮细胞相互作用和增强抗癌免疫反应来预防鼻咽癌转移。
Front Pharmacol. 2024 Apr 25;15:1355650. doi: 10.3389/fphar.2024.1355650. eCollection 2024.
2
Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer - An Overview.补充和替代医学干预在胰腺癌管理中的现状概述。
Curr Treat Options Oncol. 2023 Dec;24(12):1852-1869. doi: 10.1007/s11864-023-01146-4. Epub 2023 Dec 11.
3
Acute and repeated dose 26-week oral toxicity study of 20(S)-ginsenoside Rg3 in Kunming mice and Sprague-Dawley rats.
20(S)-人参皂苷Rg3对昆明小鼠和Sprague-Dawley大鼠的急性及重复给药26周经口毒性研究
J Ginseng Res. 2020 Mar;44(2):222-228. doi: 10.1016/j.jgr.2018.10.001. Epub 2018 Oct 19.
4
Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism.人参皂苷Rh2对奥沙利铂耐药结肠癌细胞的逆转作用及其机制
Exp Ther Med. 2019 Jul;18(1):630-636. doi: 10.3892/etm.2019.7604. Epub 2019 May 23.
5
The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism.人参皂苷 Rh2 逆转人结直肠癌细胞耐药及其机制的研究。
Hum Cell. 2018 Jul;31(3):189-198. doi: 10.1007/s13577-017-0189-3. Epub 2018 Mar 26.
6
Global deregulation of ginseng products may be a safety hazard to warfarin takers: solid evidence of ginseng-warfarin interaction.全球范围内的人参产品不受监管,可能会对服用华法林的人造成安全隐患:人参-华法林相互作用的有力证据。
Sci Rep. 2017 Jul 19;7(1):5813. doi: 10.1038/s41598-017-05825-9.
7
Network pharmacology dissection of multiscale mechanisms of herbal medicines in stage IV gastric adenocarcinoma treatment.网络药理学剖析草药在IV期胃腺癌治疗中的多尺度机制
Medicine (Baltimore). 2016 Aug;95(35):e4389. doi: 10.1097/MD.0000000000004389.
8
Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy.发酵红参提取物对接受化疗的晚期非小细胞肺癌患者的辅助作用。
Chin J Integr Med. 2017 May;23(5):331-337. doi: 10.1007/s11655-015-2146-x. Epub 2015 Jul 4.